Cutler Group’s Medifast MED Stock Holding History

Cutler Group’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,000	Closed	-$299K	–	4045
2023 Q3	$299K	Buy	+4,000	New	+$355K	0.03%	597
2020 Q3	–	Sell	-300	Closed	-$41K	–	5029
2020 Q2	$41K	Sell	300 -2,466	-89%	-$226K	﹤0.01%	1880
2020 Q1	$172K	Sell	2,766 -6,568	-70%	-$598K	0.01%	1043
2019 Q4	$1.02M	Buy	9,334 +9,134	+4,567%	+$884K	0.06%	261
2019 Q3	$20K	Buy	+200	New	+$21.5K	﹤0.01%	2187
2019 Q1	–	Sell	-300	Closed	-$38.1K	–	4464
2018 Q4	$37K	Sell	300 -500	-63%	-$85.5K	﹤0.01%	1671
2018 Q3	$177K	Buy	+800	New	+$162K	0.01%	903
2017 Q3	–	Sell	-103	Closed	-$4K	–	6354
2017 Q2	$4K	Sell	103 -221	-68%	-$9.61K	﹤0.01%	5033
2017 Q1	$14K	Sell	324 -217	-40%	-$9.34K	﹤0.01%	3719
2016 Q4	$22K	Sell	541 -2,337	-81%	-$94.1K	﹤0.01%	3379
2016 Q3	$108K	Sell	2,878 -1,540	-35%	-$55.2K	﹤0.01%	1741
2016 Q2	$146K	Buy	4,418 +3,130	+243%	+$101K	0.01%	1368
2016 Q1	$38K	Buy	+1,288	New	+$37.6K	﹤0.01%	2607

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Cutler Group's MED Position: Q4 2023 in Review

Cutler Group sold out of Medifast (MED) in Q4 2023, closing a stake of 4,000 shares — an estimated $299K sold.

Cutler Group first reported a position in MED in Q1 2016 and held it in 13 quarters. The position peaked at $1.02M in Q4 2019. 216 funds tracked by Wall St. Rank hold MED as of Q4 2023.

Cutler Group reported no remaining Medifast position as of Q4 2023 after selling out during the quarter.
Cutler Group sold 4,000 Medifast shares in Q4 2023, an estimated $299K.
Cutler Group first reported a position in Medifast in Q1 2016 and held it in 13 quarters.
Cutler Group's Medifast position peaked at $1.02M in Q4 2019.
216 funds tracked by Wall St. Rank held Medifast as of Q4 2023.

Based on Cutler Group's 13F filing for Q4 2023, filed 18 Jan 2024.